Form 4: Kestra Medical Technologies CFO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., sold 26,287 shares of common stock on August 7, 2026.

Summary

  • Open-market sale: disposed of 25,787 Common Shares at $25.87 ($667,218) on August 7, 2026; holds 61,109 after (Direct).
  • Open-market sale: disposed of 500 Common Shares at $26.33 ($13,165) on August 7, 2026; holds 60,609 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $680,383 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Vaseem Mahboob — Officer (Chief Financial Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-07Open-market saleCommon Shares25,787$26$667.2K61,109
2026-08-07Open-market saleCommon Shares500$26$13.2K60,609

Key Dates

DateDescription
2026-08-07Open-market sale (25,787 shares)
2026-08-07Open-market sale (500 shares)

Keywords

insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., bearish, Vaseem Mahboob

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.